Somaterapija, MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,030 |
| - |
| -913 |
| -913 |
| - |
| 75.62 |
| -44.98 |
| 1,706 |
| 1,343 |
| 503 |
| 2,505 |
| 2023 |
|---|
| 5,870 |
| - |
| -306 |
| -306 |
| - |
| 100.00 |
| -5.21 |
| 1,400 |
| 1,662 |
| 326 |
| 2,702 |
| 2024 |
|---|
| 8,575 |
| - |
| -312 |
| -312 |
| - |
| 100.00 |
| -3.64 |
| 1,089 |
| 194 |
| 759 |
| 416 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
8,575 €
46 % *
Sales per employee (€)
-Profit before tax (€)
-312 €
-2 % *
Net Profit (€)
-312 €-2 % *
Profit per employee (€)
-Total profitability (%)
100.00 %
0.00 % *
Net profitability (%)
-3.64 %30.13 % *
Equity (€)
1,089 €-22 % *
Amounts Payable And Liabilities (€)
194 €
-88 % *
Non-current Assets (€)
759 €
133 % *
CurrentAssets (€)
416 €-85 % *